Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.cjca.2016.01.027 http://scihub22266oqcxt.onion/10.1016/j.cjca.2016.01.027 C4921299!4921299!27117975     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Can+J+Cardiol 2016 ; 32 (7): 863-870.e5 Nephropedia Template TP {{tp|p=27117975|t=2016. Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: Cardiomyopathy and beyond |pdf=|usr=}}{{27117975}} gab.com Text Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: Cardiomyopathy and beyond JO: Can J Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=27117975 #FOAvip Tremendous strides have been made in the treatment of various oncological diseases such that patients are surviving longer and are having better quality of life. However, the success has been tainted by the iatrogenic cardiac toxicities. This is especially concerning in the younger population who are facing cardiac disease such as heart failure in their 30s and 40s as the consequence of the anthracycline?s side-effect (used for childhood leukemia and lymphoma). This resulted in the awareness of cardio-toxic effect of anticancer drugs and emergence of a new discipline: Onco-cardiology. Since then numerous anticancer drugs have been correlated to cardiomyopathy. Additionally, other cardiovascular effects have been identified which includes but no limited to the myocardial infarction, thrombosis, hypertension, arrhythmias and pulmonary hypertension. This review examines some of the anticancer agents mitigating cardiotoxicity and presents current knowledge of molecular mechanism(s). The aim of the review is to ignite awareness of emerging cardio-toxic effects as new generation of anticancer agents are being tested in clinical trials and introduced as part of therapeutic armamentarium to our oncological patients. Twit Text FOAVip Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: Cardiomyopathy and beyond ????Can J Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=27117975 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27117975 #FOAvip English Wikipedia <ref>{{Cite pmid|27117975}}</ref> Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: Cardiomyopathy and beyond #MMPMID27117975 Moudgil R; Yeh ET Can J Cardiol 2016[Jul]; 32 (7): 863-870.e5 PMID27117975show ga Tremendous strides have been made in the treatment of various oncological diseases such that patients are surviving longer and are having better quality of life. However, the success has been tainted by the iatrogenic cardiac toxicities. This is especially concerning in the younger population who are facing cardiac disease such as heart failure in their 30s and 40s as the consequence of the anthracycline?s side-effect (used for childhood leukemia and lymphoma). This resulted in the awareness of cardio-toxic effect of anticancer drugs and emergence of a new discipline: Onco-cardiology. Since then numerous anticancer drugs have been correlated to cardiomyopathy. Additionally, other cardiovascular effects have been identified which includes but no limited to the myocardial infarction, thrombosis, hypertension, arrhythmias and pulmonary hypertension. This review examines some of the anticancer agents mitigating cardiotoxicity and presents current knowledge of molecular mechanism(s). The aim of the review is to ignite awareness of emerging cardio-toxic effects as new generation of anticancer agents are being tested in clinical trials and introduced as part of therapeutic armamentarium to our oncological patients. äMechanisms of cardiotoxicity of cancer chemotherapeutic agents: Cardio(epmc).pdf DeepDyve Pubget Overpricing